Comparison of intramedullary myeloma and corresponding extramedullary soft tissue plasmacytomas using genetic mutational panel analyses

por de Haart, S J, Willems, S M, Mutis, T, Koudijs, M J, van Blokland, M T, Lokhorst, H M, de Weger, R A, Minnema, M C
Publicado 2016

Cardiac amyloidosis: the need for early diagnosis

por Oerlemans, M. I. F. J., Rutten, K. H. G., Minnema, M. C., Raymakers, R. A. P., Asselbergs, F. W., de Jonge, N.
Publicado 2019

P915: EFFICACY AND SAFETY OF DARATUMUMAB MONOTHERAPY IN NEWLY DIAGNOSED PATIENTS WITH STAGE 3B LIGHT CHAIN AMYLOIDOSIS: A PHASE 2 STUDY BY THE EUROPEAN MYELOMA NETWORK

por Kastritis, E., Minnema, M. C., Dimopoulos, M. A., Merlini, G., Theodorakakou, F., Fotiou, D., Huart, A., Belhadj, K., Gkolfinopoulos, S., Manousou, K., Sonneveld, P., Palladini, G.
Publicado 2022

P914: EFFICACY AND SAFETY OF BELANTAMAB MAFODOTIN MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY LIGHT CHAIN AMYLOIDOSIS: A PHASE 2 STUDY BY THE EUROPEAN MYELOMA NETWORK

por Kastritis, E., Palladini, G., Dimopoulos, M. A., Jaccard, A., Merlini, G., Theodorakakou, F., Fotiou, D., Minnema, M. C., Wechalekar, A., Gkolfinopoulos, S., Manousou, K., Sonneveld, P., Schönland, S.
Publicado 2022

Improving early diagnosis of pulmonary infections in patients with febrile neutropenia using low-dose chest computed tomography

por Gerritsen, M. G., Willemink, M. J., Pompe, E., van der Bruggen, T., van Rhenen, A., Lammers, J. W. J., Wessels, F., Sprengers, R. W., de Jong, P. A., Minnema, M. C.
Publicado 2017

Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1

por Oostvogels, R, Minnema, M C, van Elk, M, Spaapen, R M, te Raa, G D, Giovannone, B, Buijs, A, van Baarle, D, Kater, A P, Griffioen, M, Spierings, E, Lokhorst, H M, Mutis, T
Publicado 2013

P1130: ACALABRUTINIB IN TREATMENT-NAIVE OR RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA: 5-YEAR FOLLOW-UP OF A PHASE 2, SINGLE-ARM STUDY

por Owen, R., McCarthy, H., Rule, S., D’Sa, S., Thomas, S., Tournilhac, O., Forconi, F., José Kersten, M., Luigi Zinzani, P., Iyengar, S., Kothari, J., Minnema, M., Kastritis, E., Cheson, B., Walter, H., Greewald, D., Calvo, R., Wun, C.-C., Furman, R.
Publicado 2022

P07: RESULTS FROM THE CC-220-MM-001 DOSE-EXPANSION PHASE OF IBERDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

por van de Donk, N. W. C. J, Popat, R, Hulin, C, Jagannath, S, Oriol, A, Richardson, P. G, Facon, T, Weisel, K, Larsen, J. T, Minnema, M, Abdallah, A, Badros, A. Z, Knop, S, Stadtmauer, E. A, Chen, M, Nguyen, T. V, Amin, A, Peluso, T, Lonial, S
Publicado 2022

P1462: POPULATION-BASED REAL WORLD RESULTS OF CD19-DIRECTED CAR T-CELL THERAPY FOR PATIENTS WITH RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA: A DUTCH CAR T-CELL TUMORBOARD EXPERIE...

por Spanjaart, A. M., Pennings, E., Mutsaers, P., van Dorp, S., Jak, M., van Doesem, J., de Boer, J., Vermaat, J., Sijs-Szabo, A., van der Poel, M., Kuipers, I., Chamuleau, M., Nijhof, I., Minnema, M., Lugtenburg, P., van Meerten, T., Kersten, M. J.
Publicado 2022

P1176: RITUXIMAB IN PRIMARY CNS LYMPHOMA – LONG TERM FOLLOW-UP OF THE PHASE III HOVON 105/ALLG NHL 24 STUDY

por Doorduijn, J., Issa, S., van der Holt, B., Minnema, M., Seute, T., Durian, M., Cull, G., van der Poel, M., Stevens, W., Zijlstra, J., Nijland, M., Mason, K., Beeker, A., Brandsma, D., van den Bent, M., Gonzalez, M., de Jong, D., Bromberg, J.
Publicado 2022

P10: TALQUETAMAB, A G PROTEIN-COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED PHASE 1 RE...

por van de Donk, N. W. C. J, Minnema, M C, Berdeja, J G, Oriol, A, Krishnan, A, Rodríguez-Otero, P, Askari, E, Mateos, M, Costa, L. J, Verona, R, Ma, J, Girgis, S, Yang, S, Hilder, B. W, Russell, J, Goldberg, J. D, Chari, A
Publicado 2022

P939: SYNERGISTIC EFFECTS OF LOW DOSE BELANTAMAB MAFODOTIN IN COMBINATION WITH A GAMMA-SECRETASE INHIBITOR (NIROGACESTAT) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRM...

por Nooka, A., Lonial, S., Grosicki, S., Hus, M., Song, K., Facon, T., Callander, N. S., Ribrag, V., Uttervall, K., Quach, H., Vorobyev, V., Min, C.-K., Cheng, S., Smith, L. M., Yu, J., Collingwood, T., Holkova, B., Kremer, B. E., Gupta, I. V., Richardson, P. G., Minnema, M. C.
Publicado 2022

P1105: FINAL RESULTS OF THE PHASE I/II HOVON124/ECWM-R2 STUDY INCLUDING 2-YEAR RITUXIMAB MAINTENANCE AFTER INDUCTION WITH IXAZOMIB, RITUXIMAB AND DEXAMETHASONE IN RELAPSED WALDENST...

por Dimopoulos, M.-A., Amaador, K., Minnema, M. C., Nasserinejad, K., Kap, M., Kastritis, E., Gavriatopoulou, M., Kraan, W., Chamuleau, M. E. D., Deeren, D., Tick, L., Doorduijn, J. K., Offner, F., Böhmer, L. H., Liu, R. D., Pals, S. T., Vos, J. M., Kersten, M. J.
Publicado 2022

P1714: HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH LIGHT CHAIN AMYLOIDOSIS IN EUROPE

por Jaccard, A., Bridoux, F., Roeloffzen, W., Minnema, M. C., Bergantim, R., Hájek, R., João, C., Cibeira, M. T., Palladini, G., Schönland, S., Merlini, G., Milani, P., Dimopoulos, M. A., Ravichandran, S., Hegenbart, U., Agis, H., Gros, B., Asra, A., Dergarabetian, E., Magarotto, V., Leonidakis, A., Cheliotis, G., Sonneveld, P., Wechalekar, A., Kastritis, E.
Publicado 2022

B03 CARFILZOMIB AND LENALIDOMIDE FOR PRIMARY PLASMA CELL LEUKEMIA: FINAL RESULTS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR PATIENTS AGED ≥66 YEARS

por Musto, P., Minnema, M.C., Roeloffzen, W.W.H., Capra, A., van der Holt, B., Juul Vangsted, A., Broyl, A., Schjesvold, F., Lund, T., Silkjaer, T., Benjamin, R., Grasso, M., Lung Wu, K., Caers, J., Cavo, M., Hájek, R., Bruno, B., Gadisseur, A., Pietrantuono, G., Offidani, M., Pour, L., Sonneveld, P., Boccadoro, M., van de Donk, N.
Publicado 2023

P42 HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH TALQUETAMAB, A G PROTEIN-COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISP...

por van de Donk, N., Rasche, L., Touzeau, C., Chari, A., Schinke, C., Minnema, M., Berdeja, J., Oriol, A., Rodriguez-Otero, P., Askari, E., Mateos, M., Costa, L., Caers, J., Krishnan, A., Vishwamitra, D., Ma, J., Qin, X., Gries, K.S., Kato, K., Campagna, M., Masterson, T., Hilder, B., Tolbert, J., Renaud, T., Goldberg, J., Heuck, C., Moreau, P., San-Miguel, J.
Publicado 2023

P29 PHASE 1/2 RESULTS OF TALQUETAMAB, A G PROTEIN-COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)...

por Minnema, M.C., Chari, A., Touzeau, C., Schinke, C., Berdeja, J., Oriol, A., van, de Donk N., Otero, P.R., Askari, E., Mateos, M.V., Costa, L.J., Caers, J., Rasche, L., Krishnan, A., Vishwamitra, D., Ma, X., Qin, X., Gries, K.S., Campagna, M., Masterson, T., Hilder, B., Tolbert, J., Renaud, T., Goldberg, J.D., Heuck, C., Miguel, J.S., Moreau, P.
Publicado 2023

B02 CARFILZOMIB AND LENALIDOMIDE-BASED THERAPY FOR THE TREATMENT OF PRIMARY PLASMA CELL LEUKEMIA: RESULTS OF THE FINAL ANALYSIS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR...

por van de Donk, N., Minnema, M.C., van der Holt, B., Schjesvold, F., Wu, K.L., Capra, A., Broyl, A., Roeloffzen, W.W.H., Gadisseur, A.P.A., Pietrantuono, G., Pour, L., van der Velden, V., Lund, T., Offidani, M., Grasso, M., Giaccone, L., Cavo, M., Silkjaer, T., Caers, J., Zweegman, S., Hajek, R., Benjamin, R., Vangsted, A., Boccadoro, M., Gay, F., Sonneveld, P., Musto, P.
Publicado 2023

P1161: ASPEN: LONG-TERM FOLLOW-UP RESULTS OF A PHASE 3 RANDOMIZED TRIAL OF ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR) IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM)

por Dimopoulos, M., Opat, S., D’Sa, S., Jurczak, W., Lee, H.-P., Cull, G., Owen, R. G., Marlton, P., Wahlin, B. E., Garcia-Sanz, R., McCarthy, H., Mulligan, S., Tedeschi, A., Castillo, J. J., Czyz, J., Fernandez De Larrea Rodriguez, C., Belada, D., Libby, E., Matous, J., Motta, M., Siddiqi, T., Tani, M., Trneny, M., Minnema, M., Buske, C., Leblond, V., Treon, S. P., Trotman, J., Chan, W. Y., Schneider, J., Allewelt, H., Cohen, A., Huang, J., Tam, C. S.
Publicado 2022